AzTrials
AzTrials

Femoral Neck FracturePhase 4NCT01219062

Postoperative Pain Control After Hip Hemiarthroplasty: Intrathecal Morphine vs Periarticular Infiltration of Bupivacaine

A Phase 4 study testing morphine and Bupivacaine in people with Femoral Neck Fracture, run by Mahidol University at 2 sites in Thailand.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Falls are a common problem in elderly people which they have to receive the operation. Hemiarthroplasty is one of the common orthopedics operations. The prompt operation and good pain control will provide the good recovery and outcome. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Femoral Neck Fracture
What is being tested?
morphine and Bupivacaine
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
10 participants
Where
2 sitesThailand
Study dates
Sep 2010to Apr 2011
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age between 18-90 years
  • Co-operative, able to use PCA
  • ASA classification 1-3
  • no contraindication for Spinal Anesthesia
  • patient acceptance for spinal anesthesia
  • body weight > 30 kg.
  • BMI between 20-35
  • no history of drug allergy, e.g. Local Anesthetics, Paracetamol, etc.

Who cannot join

  • age > 90 years
  • previous Hemiarthroplasty (the same site)
  • pathological fracture such as severe infection, bone cancer

Trial locations and contacts

2 sites in 1 country.

Thailand2 sites
  • Faculty of Medicine Siriraj Hospital

    Bangkok, 10700

  • Thitima Chinachot

    Bangkok, 10700

Other trials in Thailand

About this study

Official title: Comparative of Postoperative Pain Control at 24 and 48 Hours Between Intrathecal 0.1 mg. of Morphine or Local Infiltration of 20 ml. of 0.25% Bupivacaine in Patients Post Hip Hemiarthroplasty Under Spinal Anesthesis

Falls are a common problem in elderly people which they have to receive the operation. Hemiarthroplasty is one of the common orthopedics operations. The prompt operation and good pain control will provide the good recovery and outcome. The investigators compare the efficacy of postoperative pain control between Intrathecal morphine 0.1 milligrams (mg.) with the local infiltration of 0.25% Bupivacaine for 20 milliliters (ml.) in patients received hip hemiarthroplasty under spinal anesthesia.

Read the detailed description

Study process All the patients who assigned the hip hemiarthroplasty without any exclusion criteria will be enrolled in the study and be divided into 3 groups randomly

  1. control group : the patients will be received spinal anesthesia with 0.5% Isobaric Bupivacaine and postoperative pain control by intravenous (IV) Patient - control Analgesia (PCA)
  2. Morphine group : the patients will be received 0.1 mg. of Morphine added in Isobaric Bupivacaine for spinal anesthesia and postoperative pain control by IV PCA
  3. Local group : the patients will be received spinal anesthesia and periarticular tissue infiltration with 0.25% Bupivacaine and postoperative pain control by IV PCA

Data collection

  1. Demographic data : age, sex, Body Weight, Body Mass Index (BMI), ...
  2. Pain score every 3 hours postoperatively in the first 6 hours and at the 12th hours by visual analogue scoring system
  3. Patient global assessment and patient satisfactory visual analogue scoring system at 24th and 48th hour
  4. the amount of morphine during 24 and 48 hours postoperative and the time of first dose they received
Being tested
morphine, control, Bupivacaine
Medical subject headings
Femoral Neck Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • morphineDrug

    periarticular infiltration with 0.25% Bupivacaine for 20 ml.

  • controlOther

    the patients will be received spinal anesthesia with 0.5% Isobaric Bupivacaine and postoperative pain control by intravenous (IV) Patient - control Analgesia (PCA)

  • BupivacaineDrug

    the patients will be received spinal anesthesia and periarticular tissue infiltration with 0.25% Bupivacaine and postoperative pain control by IV PCA

Study groups in NCT01219062
Study groupRoleWhat they receive
controlPlacebo comparatorThe patient will be performed spinal anesthesia alone, with postoperative PCA
Receives: Other: control
MorphineActive comparatorThe patient will received intrathecal Morphine for 0.1 mg. in Isobaric bupivacaine in spinal anesthesia and postoperative PCA
Receives: Drug: morphine
bupivacaineActive comparatorthe patients will be received spinal anesthesia and periarticular tissue infiltration with 0.25% Bupivacaine and postoperative pain control by IV PCA
Receives: Drug: Bupivacaine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Amount of Morphine consumption after Hemiarthroplasty

    Measured: 24 hours

Secondary outcomes (1)
  1. Efficacy of pain control

    Efficacy of pain control measured by

    • the amount of morphine which the patient needed to keep pain score 2-3
    • patient global assessment
    • patient satisfaction assessed by visual analogue scale
    • incidence of adverse effect such as pruritus, nausea and vomiting,...

    Measured: 48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Oct 2010 (estimated)
  2. Study startSep 2010
  3. Primary completionApr 2011
  4. Study completionApr 2011

Why it stopped: Surgeon team were not happy with the study protocol, the periarticular injection of local anesthetics

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01219062
Sponsor's protocol ID
Si391/2010
Status last verified
Oct 2016
First submitted
15 Sep 2010
Last updated
4 Oct 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing morphine and Bupivacaine in people with Femoral Neck Fracture, run by Mahidol University at 2 sites in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 4 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was stopped early (reason given: Surgeon team were not happy with the study protocol, the periarticular injection of local anesthetics). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Amount of Morphine consumption after Hemiarthroplasty (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in